• Rajashekar Vadlakonda Vikas College of Pharmacy, Kakatiya university
  • Sreenivas Enaganti
  • Raghunandan Nerella



Objectives: To predict the anticancer potentiality of some newly designed azaindole derivatives gainst human Aurora B kinase and to identify the critical features important for their activity.

Methods: Initially, the derivatives of azaindoles, (Z)-2-(oxo-1 H-pyrrolo [2,3-b] pyridine-3 (2H)-ylidene)-N-(p-substituted) hydrazine carbothioamide (scaffold A), (E)-3-((E)-substituted benzylidene hydrazono)-1H-pyrrolo[2,3-b]pyridine-2(3H)-one (scaffold B), and 1-(2-substituted acetyl)-1H- pyrrolo [2,3-b]pyridine-2,3-dione are synthesized and sketched using ACD/ChemSketch (12.0). With the 3D converted compounds, docking into the active site of the retrieved protein Aurora B kinase is carried out using LibDock module of discovery studio (DS). Further absorption, distribution, metabolism, excretion and toxicity (ADMET) properties, ligand, and structure-based pharmacophore modeling are applied using DS.

Results: Through docking and pharmacophore studies, it is revealed that compound C13 (N-{(Z)-2-[4-(dimethylamino)phenyl]ethenyl}-1H- pyrrolo[2,3-b]pyridine-3-carboxamide) shows the highest binding affinity and good pharmacophoric features with acceptable fit values of both ligand and structure-based pharmacophore models. Furthermore, the calculated ADMET properties are reliable.

Conclusion: These studies suggest that the compound C13 (N-{(Z)-2-[4-(dimethylamino)phenyl]ethenyl}-1H-pyrrolo[2,3-b]pyridine-3-carboxamide)

may act as a potent target in the anticancer therapy.

Keywords: Aneuploidy, Aurora B kinase, Azaindole, Cancer, Cell cycle, Genome stability.



Download data is not yet available.

Author Biography

Rajashekar Vadlakonda, Vikas College of Pharmacy, Kakatiya university

Pharmaceutical chemistry


Andrews PD. Aurora kinases: Shining lights on the therapeutic horizon?

Oncogene 2005;24(32):5005-15.

Bolanos-Garcia VM. Aurora kinases. Int J Biochem Cell Biol


Katayama H, Sen S. Aurora kinase inhibitors as anticancer molecules.

Biochim Biophys Acta 2010;1799(10-12):829-39.

Hochegger H, Hégarat N, Pereira-Leal JB. Aurora at the pole and equator: Overlapping functions of Aurora kinases in the mitotic spindle.

Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer


Bischoff JR, Plowman GD. The Aurora/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis. Trends Cell Biol 1999;9(11):454-9.

Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007;5(1):1-10.

Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004;14(1):29-36.

Ke YW, Dou Z, Zhang J, Yao XB. Function and regulation of Aurora/ Ipl1p kinase family in cell division. Cell Res 2003;13(2):69-81.

Jayanthan A, Ruan Y, Truong TH, Narendran A. Aurora kinases as druggable targets in pediatric leukemia: Heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents. PLoS One 2014;9(1):e102741.

Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat

Rev Cancer 2004;4(1):927-36.

Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: Conducting cell division. Nat Rev Mol Cell Biol 2007;8(10):798-812.

Kelly AE, Funabiki H. Correcting aberrant kinetochore microtubule attachments: An Aurora B-centric view. Curr Opin Cell Biol


van der Waal MS, Hengeveld RC, van der Horst A, Lens SM. Cell division control by the Chromosomal Passenger Complex. Exp Cell Res 2012;318(12):1407-20.

Cooke CA, Heck MM, Earnshaw WC. The inner centromere protein (INCENP) antigens: Movement from inner centromere to midbody during mitosis. J Cell Biol 1987;105:2053-67.

Earnshaw WC, Bernat RL. Chromosomal passengers: Toward an integrated view of mitosis. Chromosoma 1991;100(3):139-46.

Earnshaw WC, Cooke CA. Analysis of the distribution of the INCENPs throughout mitosis reveals the existence of a pathway of structural changes in the chromosomes during metaphase and early events in cleavage furrow formation. J Cell Sci 1991;98:443-61.

Adams RR, Maiato H, Earnshaw WC, Carmena M. Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J Cell Biol


Carvalho A, Carmena M, Sambade C, Earnshaw WC, Wheatley SP.

Survivin is required for stable checkpoint activation in taxol-treated

HeLa cells. J Cell Sci 2003;116:2987-98.

Honda R, Körner R, Nigg EA. Exploring the functional interactions

between Aurora B, INCENP, and survivin in mitosis. Mol Biol Cell


Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DF, Honda R, et al. Borealin: A novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol 2004;166(2):179-91.

Vader G, Kauw JJ, Medema RH, Lens SM. Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep 2006;7(1):85-92.

Bayliss R, Fry A, Haq T, Yeoh S. On the molecular mechanisms of mitotic kinase activation. Open Biol 2012;2(11):120136.



How to Cite

Vadlakonda, R., S. Enaganti, and R. Nerella. “INSILICO DISCOVERY OF HUMAN AURORA B KINASE INHIBITORS BY MOLECULAR DOCKING, PHARMACOPHORE VALIDATION AND ADMET STUDIES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 2, Feb. 2017, pp. 165-74, doi:10.22159/ajpcr.2017.v10i2.14974.



Original Article(s)